Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia

Nature Communications

Volumn 7, Issue , 2016, Pages

  Hirsch, Pierre ^a,b,c   Zhang, Yanyan ^d,e   Tang, Ruoping ^c   Joulin, Virginie ^d,e   Boutroux, Hélène ^a,b,f   Pronier, Elodie ^e   Moatti, Hannah ^a,b   Flandrin, Pascale ^a,b   Marzac, Christophe ^c   Bories, Dominique ^g   Fava, Fanny ^a   Mokrani, Hayat ^e   Betems, Aline ^e   Lorre, Florence ^c   Favier, Rémi ^c   Féger, Frédéric ^c   Mohty, Mohamad ^a   Douay, Luc ^a,b,c   Legrand, Ollivier ^a,b,c   Bilhou Nabera, Chrystèle ^a,b,c   Louache, Fawzia ^d,e   Delhommeau, François ^a,b,c   more..

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSERM   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; DNA METHYLTRANSFERASE 3A; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1;

ADAPTATION; CANCER; CELLS AND CELL COMPONENTS; CLONE; GENETIC ANALYSIS; HIERARCHICAL SYSTEM; LESION; MUTATION; TEMPORAL VARIATION;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASXL1 GENE; CANCER DIAGNOSIS; CEBPA GENE; CELL SELF-RENEWAL; CHROMOSOME 20Q; CHROMOSOME 7; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLONAL EVOLUTION; CLONAL VARIATION; CONTROLLED STUDY; DNA METHYLATION; EARLY CANCER; EPIGENETICS; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE TRANSLOCATION; GENETIC VARIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MOUSE; NONHUMAN; PHYLOGENY; TET2 GENE; ACUTE MYELOID LEUKEMIA; ANIMAL; CELL CLONE; GENE REARRANGEMENT; GENETIC EPIGENESIS; GENETICS; HEMATOPOIESIS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE CELL ANALYSIS; TIME FACTOR;

ANIMALS; BASE SEQUENCE; CLONAL EVOLUTION; CLONE CELLS; EPIGENESIS, GENETIC; GENE REARRANGEMENT; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MUTATION; SINGLE-CELL ANALYSIS; TIME FACTORS;

EID: 84983353716     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12475     Document Type: Article

References (33)

1. Döhner, H., Weisdorf, D. J. & Bloomfield, C. D. acute myeloid leukemia. N. Engl. J. Med. 373, 1136-1152 (2015).
2. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059-2074 (2013).
3. Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477-2487 (2014).
4. Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488-2498 (2014).
5. Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472-1478 (2014).
6. Busque, L. et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat. Genet. 44, 1179-1181 (2012).
7. Jan, M. et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med. 4, 149ra118 (2012).
8. Shlush, L. I. et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506, 328-333 (2014).
9. Klco, J. M. et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell 25, 379-392 (2014).
10. Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264-278 (2012).
11. Corces-Zimmerman, M. R., Hong, W.-J., Weissman, I. L., Medeiros, B. C. & Majeti, R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl Acad. Sci. USA 111, 2548-2553 (2014).
12. Moriya, K. et al. Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice. PLoS ONE 7, e37892 (2012).
13. Bäsecke, J. et al. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation. Leuk. Lymphoma 46, 265-272 (2005).
14. Wunderlich, M., Krejci, O., Wei, J. & Mulloy, J. C. Human CD34 cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability. Blood 108, 1690-1697 (2006).
15. Figueroa, M. E. et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17, 13-27 (2010).
16. Li, Y. et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood 121, 499-509 (2013).
17. Alvarez, S. et al. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia. PLoS ONE 5, e12197 (2010).
18. Aziz, A. et al. Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions. J. Clin. Invest. 123, 2169-2182 (2013).
19. El Hajj, H. et al. Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells. Blood 125, 3447-3454 (2015).
20. Dolatshad, H. et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia 29, 1092-1103 (2015).
21. Bolli, N. et al. Expression of the cytoplasmic NPM1 mutant (NPMc) causes the expansion of hematopoietic cells in zebrafish. Blood 115, 3329-3340 (2010).
22. Sportoletti, P. et al. The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. Blood 121, 3447-3458 (2013).
23. Pronier, E. et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood 118, 2551-2555 (2011).
24. Polprasert, C. et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 27, 658-670 (2015).
25. Saliba, J. et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat. Genet. 47, 1131-1140 (2015).
26. White, J. S., Zordan, A., Batzios, C. & Campbell, L. J. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH. Cancer Genet. 205, 644-652 (2012).
27. Wiemels, J. L. et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99, 3801-3805 (2002).
28. Wong, T. N. et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518, 552-555 (2015).
29. Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506-510 (2012).
30. Ma, X. et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-Acute lymphoblastic leukaemia. Nat. Commun. 6, 6604 (2015).
31. Gabert, J. et al. Standardization and quality control studies of real-Time quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe Against Cancer program. Leukemia 17, 2318-2357 (2003).
32. Scholl, C. et al. Development of a real-Time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia. Genes Chromosomes Cancer 38, 274-280 (2003).
33. Zhang, Y. et al. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. Cell Death Dis. 3, e396 (2012).